IVAC’s VIRA Chatbot Receives Silver Anthem Award for Innovative Approach to Vaccine Communication
COVID-19 vaccine uptake has plateaued globally, largely in part due to rampant misinformation about the vaccine’s safety and effectiveness. To combat this phenomenon, IVAC launched VIRA, the COVID-19 vaccine chatbot, at the peak of the pandemic in July 2021. VIRA was developed in partnership with IBM Research with the goal of providing evidence-based, credible, and up-to-date information about the COVID-19 vaccines. The chatbot’s innovative technology was recently recognized by the Anthem Awards, which celebrate purpose and mission-driven work from people, companies, and organizations worldwide. Out of nearly 2,000 submissions from 43 countries, VIRA received a Silver award in the Health Innovations category. |
|
|
